Rib-X Pharmaceuticals Garners $5,500,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2cfa96c8-dbb3-4f8b-b4d4-b9cfcd36445f&Preview=1 -
Date
1/28/2011 -
Company Name
Rib-X Pharmaceuticals -
Mailing Address
300 George Street New Haven, CT 06511 -
Company Description
Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The company’s underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the 50S subunit of the ribosome, which performs an essential role in the fundamental process of protein synthesis. -
Website
http://www.rib-x.com -
Transaction Type
Debt -
Transaction Amount
$5,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. Amount included options, warrants or other rights to acquire another security. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
